Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemotherapy +/- Darbepoetin Alfa in Primary Breast Cancer
NCT00544232Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Aug 2002
- Primary completion
- Sep 2006
- Modality
- Colony Stimulating Factors, DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 3 trial of epirubicin, Paclitaxel Micelles for Injection, cyclophosphamide, methotrexate, fluorouracil in breast cancer, sponsored by GBG Forschungs. Started Aug 2002; status: completed.
02
Drugs
epirubicinPaclitaxel Micelles for Injectioncyclophosphamidemethotrexatefluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00544232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544232.